Yong Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yong Chen has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Jian Ping Gong
Hokkaido University
2 shared publications Jianping Gong
Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
2 shared publications- Shiming Jiang
Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Medical College Street, Yuzhong District, 404100, Chongqing, China
2 shared publications Yachao Zhu
2 shared publications- Bin Lu
Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
1 shared publication - Bin Yu
Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
1 shared publication
Latest Publications
- Open Access
- 17 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (22) , 9017
Deep Learning Reconstruction for High-b-Value FOCUS DWI in Pancreatic Cancer: Image Quality Improvement and Effects on ADC Measurements
Objectives: To evaluate whether deep learning reconstruction (DLR) improves pancreas-referenced image quality in high-b-value field-of-view optimized and constrained undistorted single-shot diffusion-weighted imaging (FOCUS DWI) for pancreatic cancer, and to assess reconstruction-related changes in apparent diffusion coefficient (ADC) measurements in tumor and non-tumorous pancreatic regions. Methods: This prospective single-center study included 68 patients with pathologically confirmed pancreatic cancer who underwent 3.0-T pancreatic MRI. FOCUS DWI was acquired with b values of 0, 1000, 1500, and 2000 s/mm2 and reconstructed with and without DLR. Quantitative metrics included lesion signal-to-noise ratio (SNR), lesion-to-pancreas contrast-to-noise ratio (CNR), lesion-to-pancreas signal intensity ratio (LP-SIR), and ADC values in tumor regions and non-tumorous pancreatic parenchyma. Two abdominal radiologists independently assessed composite image quality and lesion conspicuity using a 5-point ordinal scale. Paired comparisons were performed with Holm correction across b values. Results: DLR significantly increased lesion SNR and lesion-to-pancreas CNR at b = 1000, 1500, and 2000 s/mm2 (all Holm-adjusted p < 0.001). Absolute image quality was highest at b = 1000 s/mm2, whereas the greatest DLR-related lesion SNR gain occurred at b = 1500 s/mm2. LP-SIR remained broadly stable after DLR (Holm-adjusted p = 0.767, 1.000, and 1.000). Tumor regions showed lower ADC values than non-tumorous pancreatic parenchyma across all b values and reconstruction conditions (all p < 0.001), while ADC values did not differ significantly between DLR and non-DLR reconstructions within either region (p = 0.414–0.794). Qualitative scores improved after DLR for both readers at all b values (all Holm-adjusted p < 0.001), with weighted κ ranging from 0.717 to 0.896. Conclusions: DLR improved ROI-based quantitative image-quality metrics and qualitative image assessment in high-b-value pancreatic FOCUS DWI, with the greatest lesion SNR gain at b = 1500 s/mm2. No statistically significant reconstruction-related differences in ADC measurements were observed within tumor or non-tumorous pancreatic regions.
- 17 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (22) , 9017
Open AccessDeep Learning Reconstruction for High-b-Value FOCUS DWI in Pancreatic Cancer: Image Quality Improvement and Effects on ADC Measurements
Objectives: To evaluate whether deep learning reconstruction (DLR) improves pancreas-referenced image quality in high-b-value field-of-view optimized and constrained undistorted single-shot diffusion-weighted imaging (FOCUS DWI) for pancreatic cancer, and to assess reconstruction-related changes in apparent diffusion coefficient (ADC) measurements in tumor and non-tumorous pancreatic regions. Methods: This prospective single-center study included 68 patients with pathologically confirmed pancreatic cancer who underwent 3.0-T pancreatic MRI. FOCUS DWI was acquired with b values of 0, 1000, 1500, and 2000 s/mm2 and reconstructed with and without DLR. Quantitative metrics included lesion signal-to-noise ratio (SNR), lesion-to-pancreas contrast-to-noise ratio (CNR), lesion-to-pancreas signal intensity ratio (LP-SIR), and ADC values in tumor regions and non-tumorous pancreatic parenchyma. Two abdominal radiologists independently assessed composite image quality and lesion conspicuity using a 5-point ordinal scale. Paired comparisons were performed with Holm correction across b values. Results: DLR significantly increased lesion SNR and lesion-to-pancreas CNR at b = 1000, 1500, and 2000 s/mm2 (all Holm-adjusted p < 0.001). Absolute image quality was highest at b = 1000 s/mm2, whereas the greatest DLR-related lesion SNR gain occurred at b = 1500 s/mm2. LP-SIR remained broadly stable after DLR (Holm-adjusted p = 0.767, 1.000, and 1.000). Tumor regions showed lower ADC values than non-tumorous pancreatic parenchyma across all b values and reconstruction conditions (all p < 0.001), while ADC values did not differ significantly between DLR and non-DLR reconstructions within either region (p = 0.414–0.794). Qualitative scores improved after DLR for both readers at all b values (all Holm-adjusted p < 0.001), with weighted κ ranging from 0.717 to 0.896. Conclusions: DLR improved ROI-based quantitative image-quality metrics and qualitative image assessment in high-b-value pancreatic FOCUS DWI, with the greatest lesion SNR gain at b = 1500 s/mm2. No statistically significant reconstruction-related differences in ADC measurements were observed within tumor or non-tumorous pancreatic regions.
- Open Access
- 7 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Machine learning-based prognostic signature integrating mitochondrial function and programmed cell death patterns in pancreatic adenocarcinoma
The interplay between mitochondria and programmed cell deaths (PCD) is associated with tumor pathogenesis. However, the specific roles of genes related to mitochondrial function and PCD patterns in pancreatic adenocarcinoma (PAAD) remain unclear. Though integrated multi-omics and bioinformatic analyses, we identified PCD activity-associated mitochondrial function genes (PCDMGs), and constructed a robust prognostic signature containing eight PCDMGs via CoxBoost+StepCox algorithms[both] algorithms. The constructed nomogram was validated to have superior prognostic predictive efficacy. Multiple-dimensional analyses demonstrated that the prognostic signature was significantly correlated with oncogenic pathways activation, tumor microenvironment (TME) reconstruction, and genomic variants. Drug sensitivity analysis indicated the high-risk group derived more benefits from immunotherapy but less from chemotherapy and targeted therapy. A ceRNA regulatory network was also constructed to elucidate the potential molecular mechanism of PAAD, and molecular docking simulations revealed favorable binding of the target proteins to prevalent anticancer agents. Finally, qRT-PCR in 6 PAAD patients confirmed the elevated expression levels of the eight model genes in tumor tissues, corroborating the bioinformatic findings. In conclusion, the prognostic signature and nomogram can stratify PAAD patients by prognosis and drug sensitivity, thus assisting clinicians in treatment optimization and clinical decision-making .
- 7 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessMachine learning-based prognostic signature integrating mitochondrial function and programmed cell death patterns in pancreatic adenocarcinoma
The interplay between mitochondria and programmed cell deaths (PCD) is associated with tumor pathogenesis. However, the specific roles of genes related to mitochondrial function and PCD patterns in pancreatic adenocarcinoma (PAAD) remain unclear. Though integrated multi-omics and bioinformatic analyses, we identified PCD activity-associated mitochondrial function genes (PCDMGs), and constructed a robust prognostic signature containing eight PCDMGs via CoxBoost+StepCox algorithms[both] algorithms. The constructed nomogram was validated to have superior prognostic predictive efficacy. Multiple-dimensional analyses demonstrated that the prognostic signature was significantly correlated with oncogenic pathways activation, tumor microenvironment (TME) reconstruction, and genomic variants. Drug sensitivity analysis indicated the high-risk group derived more benefits from immunotherapy but less from chemotherapy and targeted therapy. A ceRNA regulatory network was also constructed to elucidate the potential molecular mechanism of PAAD, and molecular docking simulations revealed favorable binding of the target proteins to prevalent anticancer agents. Finally, qRT-PCR in 6 PAAD patients confirmed the elevated expression levels of the eight model genes in tumor tissues, corroborating the bioinformatic findings. In conclusion, the prognostic signature and nomogram can stratify PAAD patients by prognosis and drug sensitivity, thus assisting clinicians in treatment optimization and clinical decision-making .
- Open Access
- 31 March 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17
Downregulated PLAU alleviates acute rejection after liver transplantation by targeting Ptgs2 in macrophages
Background: Acute rejection (AR) is a major determinant of poor prognosis after liver transplantation (LT), and macrophage M1-polarization can induce AR. Urokinase-type plasminogen activator (PLAU) has been implicated in the regulation of several liver diseases, but its role in AR remains unclear. Methods: In this study, through bioinformatics analysis and transcriptome sequencing, we find that PLAU and prostaglandin-endoperoxide synthase 2 (Ptgs2) can regulate macrophage polarization. To elucidate the effects of PLAU and Ptgs2 on AR, dynamic changes in PLAU and Ptgs2 expression are detected in both peripheral blood mononuclear cells (PBMCs) from clinical LT patients and hepatic macrophages from LT rats. Subsequently, to investigate the specific regulatory roles in macrophage M1-polarization and AR, downregulating PLAU and Ptgs2 rescue experiments are conducted in vivo and in vitro . Finally, potential signaling pathways are further identified through KEGG enrichment analysis. Results: The expression of PLAU and Ptgs2 is increased in PBMCs from LT patients and in macrophages from LT rats, and most significantly on postoperative day 7. Downregulating PLAU alleviates AR and suppresses M1-polarization of macrophages. However, Ptgs2 rescue exacerbates AR and promotes M1-polarization of macrophages. The potential mechanism involves regulating the Protein kinase B/Nuclear factor kappa B (AKT/NF-κB) pathway. Conclusion: In summary, downregulated the PLAU/Ptgs2 axis can attenuate AR by regulating macrophage polarization, offering a promising new therapeutic target for preventing and treating AR.
- 31 March 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17
Open AccessDownregulated PLAU alleviates acute rejection after liver transplantation by targeting Ptgs2 in macrophages
Background: Acute rejection (AR) is a major determinant of poor prognosis after liver transplantation (LT), and macrophage M1-polarization can induce AR. Urokinase-type plasminogen activator (PLAU) has been implicated in the regulation of several liver diseases, but its role in AR remains unclear. Methods: In this study, through bioinformatics analysis and transcriptome sequencing, we find that PLAU and prostaglandin-endoperoxide synthase 2 (Ptgs2) can regulate macrophage polarization. To elucidate the effects of PLAU and Ptgs2 on AR, dynamic changes in PLAU and Ptgs2 expression are detected in both peripheral blood mononuclear cells (PBMCs) from clinical LT patients and hepatic macrophages from LT rats. Subsequently, to investigate the specific regulatory roles in macrophage M1-polarization and AR, downregulating PLAU and Ptgs2 rescue experiments are conducted in vivo and in vitro . Finally, potential signaling pathways are further identified through KEGG enrichment analysis. Results: The expression of PLAU and Ptgs2 is increased in PBMCs from LT patients and in macrophages from LT rats, and most significantly on postoperative day 7. Downregulating PLAU alleviates AR and suppresses M1-polarization of macrophages. However, Ptgs2 rescue exacerbates AR and promotes M1-polarization of macrophages. The potential mechanism involves regulating the Protein kinase B/Nuclear factor kappa B (AKT/NF-κB) pathway. Conclusion: In summary, downregulated the PLAU/Ptgs2 axis can attenuate AR by regulating macrophage polarization, offering a promising new therapeutic target for preventing and treating AR.
- 15 November 2025
- Published by MyJove Corporation
- No. 225,p. e69311
JoVE Video Dataset
Laparoscopic radical resection for hilar cholangiocarcinoma with vascular invasion is technically demanding but feasible in selected cases when performed by an experienced hepatobiliary surgical team. Precise minimally invasive technical execution and systematic surgical workflow organization are critical for mitigating surgical risks. We present a patient with Bismuth type IV HCCA with portal vein invasion who underwent a fully laparoscopic radical resection. The key surgical steps were as follows: (1) "en bloc" resection of hilar lymph nodes and the perihilar neural plexus; (2) segmental resection of the invaded portal vein followed by continuous suture reconstruction; and (3) microsurgical plasty of multiple bile duct orifices in conjunction with Roux-en-Y hepaticojejunostomy. The surgery was completed in 6 h, with an estimated blood loss of 200 mL and without conversion to open laparotomy. Postoperative pathological examination confirmed R0 resection with no lymph node metastases. No postoperative complications, including biliary leakage, haemorrhage, or infection, occurred. The patient remains under surveillance. Follow-up occurred at 1 month and 3 months after surgery, and subsequently occurs every 3 months. Assessments include liver function tests, tumour marker assays, and imaging (ultrasound, CT, or MRI).
- 15 November 2025
- Published by MyJove Corporation
- No. 225,p. e69311
JoVE Video Dataset
Laparoscopic radical resection for hilar cholangiocarcinoma with vascular invasion is technically demanding but feasible in selected cases when performed by an experienced hepatobiliary surgical team. Precise minimally invasive technical execution and systematic surgical workflow organization are critical for mitigating surgical risks. We present a patient with Bismuth type IV HCCA with portal vein invasion who underwent a fully laparoscopic radical resection. The key surgical steps were as follows: (1) "en bloc" resection of hilar lymph nodes and the perihilar neural plexus; (2) segmental resection of the invaded portal vein followed by continuous suture reconstruction; and (3) microsurgical plasty of multiple bile duct orifices in conjunction with Roux-en-Y hepaticojejunostomy. The surgery was completed in 6 h, with an estimated blood loss of 200 mL and without conversion to open laparotomy. Postoperative pathological examination confirmed R0 resection with no lymph node metastases. No postoperative complications, including biliary leakage, haemorrhage, or infection, occurred. The patient remains under surveillance. Follow-up occurred at 1 month and 3 months after surgery, and subsequently occurs every 3 months. Assessments include liver function tests, tumour marker assays, and imaging (ultrasound, CT, or MRI).
- 14 November 2025
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 225,p. e69311
Laparoscopic Radical Resection for Hilar Cholangiocarcinoma with Portal Vein Invasions
Laparoscopic radical resection for hilar cholangiocarcinoma with vascular invasion is technically demanding but feasible in selected cases when performed by an experienced hepatobiliary surgical team. Precise minimally invasive technical execution and systematic surgical workflow organization are critical for mitigating surgical risks. We present a patient with Bismuth type IV HCCA with portal vein invasion who underwent a fully laparoscopic radical resection. The key surgical steps were as follows: (1) "en bloc" resection of hilar lymph nodes and the perihilar neural plexus; (2) segmental resection of the invaded portal vein followed by continuous suture reconstruction; and (3) microsurgical plasty of multiple bile duct orifices in conjunction with Roux-en-Y hepaticojejunostomy. The surgery was completed in 6 h, with an estimated blood loss of 200 mL and without conversion to open laparotomy. Postoperative pathological examination confirmed R0 resection with no lymph node metastases. No postoperative complications, including biliary leakage, haemorrhage, or infection, occurred. The patient remains under surveillance. Follow-up occurred at 1 month and 3 months after surgery, and subsequently occurs every 3 months. Assessments include liver function tests, tumour marker assays, and imaging (ultrasound, CT, or MRI).
- 14 November 2025
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 225,p. e69311
Laparoscopic Radical Resection for Hilar Cholangiocarcinoma with Portal Vein Invasions
Laparoscopic radical resection for hilar cholangiocarcinoma with vascular invasion is technically demanding but feasible in selected cases when performed by an experienced hepatobiliary surgical team. Precise minimally invasive technical execution and systematic surgical workflow organization are critical for mitigating surgical risks. We present a patient with Bismuth type IV HCCA with portal vein invasion who underwent a fully laparoscopic radical resection. The key surgical steps were as follows: (1) "en bloc" resection of hilar lymph nodes and the perihilar neural plexus; (2) segmental resection of the invaded portal vein followed by continuous suture reconstruction; and (3) microsurgical plasty of multiple bile duct orifices in conjunction with Roux-en-Y hepaticojejunostomy. The surgery was completed in 6 h, with an estimated blood loss of 200 mL and without conversion to open laparotomy. Postoperative pathological examination confirmed R0 resection with no lymph node metastases. No postoperative complications, including biliary leakage, haemorrhage, or infection, occurred. The patient remains under surveillance. Follow-up occurred at 1 month and 3 months after surgery, and subsequently occurs every 3 months. Assessments include liver function tests, tumour marker assays, and imaging (ultrasound, CT, or MRI).
- Open Access
- 2 August 2024
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 12, 1408852
Overcoming treatment resistance in cholangiocarcinoma: current strategies, challenges, and prospects
Significant advancements in our understanding and clinical treatment of cholangiocarcinoma (CCA) have been achieved over the past 5 years. Groundbreaking studies have illuminated the immune landscape and pathological characteristics of the tumor microenvironment in CCA. The development of immune- and metabolism-based classification systems has enabled a nuanced exploration of the tumor microenvironment and the origins of CCA, facilitating a detailed understanding of tumor progression modulation. Despite these insights, targeted therapies have not yet yielded satisfactory clinical results, highlighting the urgent need for innovative therapeutic strategies. This review delineates the complexity and heterogeneity of CCA, examines the current landscape of therapeutic strategies and clinical trials, and delves into the resistance mechanisms underlying targeted therapies. Finally, from a single-cell and spatial transcriptomic perspective, we address the challenge of therapy resistance, discussing emerging mechanisms and potential strategies to overcome this barrier and enhance treatment efficacy.
- 2 August 2024
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 12, 1408852
Open AccessOvercoming treatment resistance in cholangiocarcinoma: current strategies, challenges, and prospects
Significant advancements in our understanding and clinical treatment of cholangiocarcinoma (CCA) have been achieved over the past 5 years. Groundbreaking studies have illuminated the immune landscape and pathological characteristics of the tumor microenvironment in CCA. The development of immune- and metabolism-based classification systems has enabled a nuanced exploration of the tumor microenvironment and the origins of CCA, facilitating a detailed understanding of tumor progression modulation. Despite these insights, targeted therapies have not yet yielded satisfactory clinical results, highlighting the urgent need for innovative therapeutic strategies. This review delineates the complexity and heterogeneity of CCA, examines the current landscape of therapeutic strategies and clinical trials, and delves into the resistance mechanisms underlying targeted therapies. Finally, from a single-cell and spatial transcriptomic perspective, we address the challenge of therapy resistance, discussing emerging mechanisms and potential strategies to overcome this barrier and enhance treatment efficacy.
- Open Access
- 3 August 2023
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 11, 1179077
Role of Kupffer cells in tolerance induction after liver transplantation
Currently, liver transplantation has reached a level of maturity where it is considered an effective treatment for end-stage liver disease and can significantly prolong the survival time of patients. However, acute and chronic rejection remain major obstacles to its efficacy. Although long-term use of immunosuppressants can prevent rejection, it is associated with serious side effects and significant economic burden for patients. Therefore, the investigation of induced immune tolerance holds crucial theoretical significance and socio-economic value. In fact, the establishment of immune tolerance in liver transplantation is intricately linked to the unique innate immune system of the liver. Kupffer cells, as a crucial component of this system, play a pivotal role in maintaining the delicate balance between inflammatory response and immune tolerance following liver transplantation. The important roles of different functions of Kupffer cells, such as phagocytosis, cell polarization, antigen presentation and cell membrane proteins, in the establishment of immune tolerance after transplantation is comprehensively summarized in this paper. Providing theoretical basis for further study and clinical application of Kupffer cells in liver transplantation.
- 3 August 2023
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 11, 1179077
Open AccessRole of Kupffer cells in tolerance induction after liver transplantation
Currently, liver transplantation has reached a level of maturity where it is considered an effective treatment for end-stage liver disease and can significantly prolong the survival time of patients. However, acute and chronic rejection remain major obstacles to its efficacy. Although long-term use of immunosuppressants can prevent rejection, it is associated with serious side effects and significant economic burden for patients. Therefore, the investigation of induced immune tolerance holds crucial theoretical significance and socio-economic value. In fact, the establishment of immune tolerance in liver transplantation is intricately linked to the unique innate immune system of the liver. Kupffer cells, as a crucial component of this system, play a pivotal role in maintaining the delicate balance between inflammatory response and immune tolerance following liver transplantation. The important roles of different functions of Kupffer cells, such as phagocytosis, cell polarization, antigen presentation and cell membrane proteins, in the establishment of immune tolerance after transplantation is comprehensively summarized in this paper. Providing theoretical basis for further study and clinical application of Kupffer cells in liver transplantation.
- 30 May 2022
- Published by Elsevier in Cellular Immunology
- Vol. 378, 104556
Rubicon promotes the M2 polarization of Kupffer cells via LC3-associated phagocytosis-mediated clearance to improve liver transplantation
- 30 May 2022
- Published by Elsevier in Cellular Immunology
- Vol. 378, 104556
Rubicon promotes the M2 polarization of Kupffer cells via LC3-associated phagocytosis-mediated clearance to improve liver transplantation
- Open Access
- 26 March 2020
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 45 (6) , 1875-1887
Suberoylanilide hydroxamic acid alleviates orthotopic liver transplantation‑induced hepatic ischemia‑reperfusion injury by regulating the AKT/GSK3β/NF‑κB and AKT/mTOR pathways in rat Kupffer cells
Multiple mechanisms are involved in regulating hepatic ischemia‑reperfusion injury (IRI), in which Kupffer cells (KCs), which are liver‑resident macrophages, play critical roles by regulating inflammation and the immune response. Suberoylanilide hydroxamic acid (SAHA), a pan‑histone deacetylase inhibitor, has anti‑inflammatory effects and induces autophagy. To investigate whether SAHA ameliorates IRI and the mechanisms by which SAHA exerts its effects, an orthotopic liver transplantation (OLT) rat model was established after treatment with SAHA. The results showed that SAHA effectively ameliorated OLT‑induced IRI by reducing M1 polarization of KCs through inhibition of the AKT/glycogen synthase kinase (GSK)3β/NF‑κB signaling pathway. Furthermore, the present study found that SAHA upregulates autophagy 5 protein (ATG5)/LC3B in KCs through the AKT/mTOR signaling pathway and inhibition of autophagy by knockdown of ATG5 in KCs partly impaired the protective effect of SAHA on IR‑injured liver. Therefore, the current study demonstrated that SAHA reduces M1 polarization of KCs by inhibiting the AKT/GSK3β/NF‑κB pathway and upregulates autophagy in KCs through the AKT/mTOR signaling pathway, which both alleviate OLT‑induced IRI. The present study revealed that SAHA may be a novel treatment for the amelioration of OLT‑induced IRI.
- 26 March 2020
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 45 (6) , 1875-1887
Open AccessSuberoylanilide hydroxamic acid alleviates orthotopic liver transplantation‑induced hepatic ischemia‑reperfusion injury by regulating the AKT/GSK3β/NF‑κB and AKT/mTOR pathways in rat Kupffer cells
Multiple mechanisms are involved in regulating hepatic ischemia‑reperfusion injury (IRI), in which Kupffer cells (KCs), which are liver‑resident macrophages, play critical roles by regulating inflammation and the immune response. Suberoylanilide hydroxamic acid (SAHA), a pan‑histone deacetylase inhibitor, has anti‑inflammatory effects and induces autophagy. To investigate whether SAHA ameliorates IRI and the mechanisms by which SAHA exerts its effects, an orthotopic liver transplantation (OLT) rat model was established after treatment with SAHA. The results showed that SAHA effectively ameliorated OLT‑induced IRI by reducing M1 polarization of KCs through inhibition of the AKT/glycogen synthase kinase (GSK)3β/NF‑κB signaling pathway. Furthermore, the present study found that SAHA upregulates autophagy 5 protein (ATG5)/LC3B in KCs through the AKT/mTOR signaling pathway and inhibition of autophagy by knockdown of ATG5 in KCs partly impaired the protective effect of SAHA on IR‑injured liver. Therefore, the current study demonstrated that SAHA reduces M1 polarization of KCs by inhibiting the AKT/GSK3β/NF‑κB pathway and upregulates autophagy in KCs through the AKT/mTOR signaling pathway, which both alleviate OLT‑induced IRI. The present study revealed that SAHA may be a novel treatment for the amelioration of OLT‑induced IRI.
- Retracted
- 29 December 2017
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 32 (4) , 298-303
RETRACTED: Liver X Receptors Activation Attenuates Ischemia Reperfusion Injury of Liver Graft in Rats
Purpose: Suppression of the Toll like receptor 4 (TLR4)-nuclear factor-κB (NF-κB) signaling was critical in protection against liver IRI. Previous studies revealed that Liver X receptors (LXRs) activation could antagonize TLR4-NF-κB signaling. The purpose of this study is to determine whether LXRs agonist GW3965 can suppress the TLR4-NF-κB signaling during liver transplantation and protect ischemia-reperfusion injury (IRI). Materials and Methods: Sprague Dawley (SD) rats were used to perform orthotropic liver transplantation. Donors were pretreatment with GW3965 (0.3 mg/kg) through caudal vein injection 30 min before the surgery. The followings were analyzed after transplantation: alanine aminotransferase (ALT), interleukin 6 (IL-6) and tumor necrosis factor α (TNF-α) level in serum, ATP binding cassette transporter A1 (Abca1) expression, NF-κB transcriptional activity, apoptosis and histological injury. Results: GW3965 pretreatment significantly ameliorated the degree of IRI associated with the effects of upregulating Abca1 expression, inhibiting NF-κB transcriptional activity, and downregulating TNF-α and IL-6 level. Conclusion: LXRs activation attenuated hepatic IRI by preventing TLR4–NF-κB signaling.
- 29 December 2017
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 32 (4) , 298-303
RetractedRETRACTED: Liver X Receptors Activation Attenuates Ischemia Reperfusion Injury of Liver Graft in Rats
Purpose: Suppression of the Toll like receptor 4 (TLR4)-nuclear factor-κB (NF-κB) signaling was critical in protection against liver IRI. Previous studies revealed that Liver X receptors (LXRs) activation could antagonize TLR4-NF-κB signaling. The purpose of this study is to determine whether LXRs agonist GW3965 can suppress the TLR4-NF-κB signaling during liver transplantation and protect ischemia-reperfusion injury (IRI). Materials and Methods: Sprague Dawley (SD) rats were used to perform orthotropic liver transplantation. Donors were pretreatment with GW3965 (0.3 mg/kg) through caudal vein injection 30 min before the surgery. The followings were analyzed after transplantation: alanine aminotransferase (ALT), interleukin 6 (IL-6) and tumor necrosis factor α (TNF-α) level in serum, ATP binding cassette transporter A1 (Abca1) expression, NF-κB transcriptional activity, apoptosis and histological injury. Results: GW3965 pretreatment significantly ameliorated the degree of IRI associated with the effects of upregulating Abca1 expression, inhibiting NF-κB transcriptional activity, and downregulating TNF-α and IL-6 level. Conclusion: LXRs activation attenuated hepatic IRI by preventing TLR4–NF-κB signaling.